These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3932308)

  • 1. Macrolides, lincosamides and streptogramins--early observations on their modes of action.
    Vázquez D
    J Antimicrob Chemother; 1985 Jul; 16 Suppl A():225-6. PubMed ID: 3932308
    [No Abstract]   [Full Text] [Related]  

  • 2. [Resistance to macrolides, lincosamides and streptogramins in infections by Streptococcus pneumoniae].
    Alonso Manzanares MA; Gutíerrez Zufiaurre MN; Muñoz Bellido JL; García-Rodríguez JA
    Med Clin (Barc); 1998 Feb; 110 Suppl 1():25-30. PubMed ID: 9717157
    [No Abstract]   [Full Text] [Related]  

  • 3. Inducible resistance to macrolides, lincosamides and streptogramin type B antibiotics: the resistance phenotype, its biological diversity, and structural elements that regulate expression--a review.
    Weisblum B
    J Antimicrob Chemother; 1985 Jul; 16 Suppl A():63-90. PubMed ID: 3932311
    [No Abstract]   [Full Text] [Related]  

  • 4. Gene heterogeneity for resistance to macrolides, lincosamides and streptogramins in Enterobacteriaceae.
    Mabilat C; Courvalin P
    Ann Inst Pasteur Microbiol; 1988; 139(6):677-81. PubMed ID: 3150940
    [No Abstract]   [Full Text] [Related]  

  • 5. Mechanism of action of streptogramins and macrolides.
    Vannuffel P; Cocito C
    Drugs; 1996; 51 Suppl 1():20-30. PubMed ID: 8724813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification.
    Leclercq R; Courvalin P
    Antimicrob Agents Chemother; 1991 Jul; 35(7):1267-72. PubMed ID: 1929280
    [No Abstract]   [Full Text] [Related]  

  • 7. Intrinsic and unusual resistance to macrolide, lincosamide, and streptogramin antibiotics in bacteria.
    Leclercq R; Courvalin P
    Antimicrob Agents Chemother; 1991 Jul; 35(7):1273-6. PubMed ID: 1929281
    [No Abstract]   [Full Text] [Related]  

  • 8. [Classification, structure, pharmacokinetic and mode of action of macrolides, lincosamides and streptogramins. Resistance phenomena].
    Leclercq R; Bismuth R
    Rev Prat; 1988 May; 38(16):1005-10, 1013-4. PubMed ID: 3136540
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative evaluation of macrolides, lincosamides and streptogramins in staphylococcal infections.
    Modai J
    J Antimicrob Chemother; 1985 Jul; 16 Suppl A():195-7. PubMed ID: 3932302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding parameters and microbiological activity of macrolides, lincosamides and streptogramins against Staphylococcus aureus.
    Fournet MP; Barre J; Zini R; Deforges L; Duval J; Tillement JP
    J Pharm Pharmacol; 1987 Apr; 39(4):319-22. PubMed ID: 2884302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of macrolides, lincosamides and streptogramins.
    Osono T; Umezawa H
    J Antimicrob Chemother; 1985 Jul; 16 Suppl A():151-66. PubMed ID: 3932301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants.
    Roberts MC; Sutcliffe J; Courvalin P; Jensen LB; Rood J; Seppala H
    Antimicrob Agents Chemother; 1999 Dec; 43(12):2823-30. PubMed ID: 10582867
    [No Abstract]   [Full Text] [Related]  

  • 13. Evolution and epidemiology of MLS resistance.
    Duval J
    J Antimicrob Chemother; 1985 Jul; 16 Suppl A():137-49. PubMed ID: 3932300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent developments in streptogramin research.
    Barrière JC; Berthaud N; Beyer D; Dutka-Malen S; Paris JM; Desnottes JF
    Curr Pharm Des; 1998 Apr; 4(2):155-80. PubMed ID: 10197038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and mechanism of resistance against macrolides, lincosamides, and streptogramins among Enterococcus faecium isolates from food-producing animals and hospital patients in Belgium.
    De Graef EM; Decostere A; De Leener E; Goossens H; Baele M; Haesebrouck F
    Microb Drug Resist; 2007; 13(2):135-41. PubMed ID: 17650967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of tetracycline and macrolide-lincosamide-streptogramin B resistance genes in anaerobic bacteria.
    Roberts MC
    Clin Infect Dis; 1995 Jun; 20 Suppl 2():S367-9. PubMed ID: 7548600
    [No Abstract]   [Full Text] [Related]  

  • 17. Evolution and present situation of Staphylococcus aureus sensitivity to MLS in hospital (1975-83).
    Thabaut A; Meyran M; Huerre M
    J Antimicrob Chemother; 1985 Jul; 16 Suppl A():205-7. PubMed ID: 3932304
    [No Abstract]   [Full Text] [Related]  

  • 18. [Selection of constitutive mutants of gram-positive cocci inducible resistant to macrolides, lincosamides and streptogramins (MLS): comparison of the selective effects of the MLS].
    Leclercq R; Bauduret F; Soussy CJ
    Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):568-72. PubMed ID: 2508040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrolides--lincosamides--streptogramins. Based on papers presented at an international symposium held in Paris, 9/10 February 1984.
    J Antimicrob Chemother; 1985 Jul; 16 Suppl A():1-226. PubMed ID: 3932296
    [No Abstract]   [Full Text] [Related]  

  • 20. Should clindamycin be used as treatment of patients with infections caused by erythromycin-resistant staphylococci?
    Panagea S; Perry JD; Gould FK
    J Antimicrob Chemother; 1999 Oct; 44(4):581-2. PubMed ID: 10588329
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.